341 related articles for article (PubMed ID: 29725419)
21. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
[TBL] [Abstract][Full Text] [Related]
22. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
23. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
24. TRPC1/3/6 inhibition attenuates the TGF-β1-induced epithelial-mesenchymal transition in gastric cancer via the Ras/Raf1/ERK signaling pathway.
Ge P; Wei L; Zhang M; Hu B; Wang K; Li Y; Liu S; Wang J; Li Y
Cell Biol Int; 2018 Aug; 42(8):975-984. PubMed ID: 29570903
[TBL] [Abstract][Full Text] [Related]
25. Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.
Wu ST; Sun GH; Hsu CY; Huang CS; Wu YH; Wang HH; Sun KH
Exp Biol Med (Maywood); 2011 Sep; 236(9):1022-9. PubMed ID: 21856755
[TBL] [Abstract][Full Text] [Related]
26. Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells.
Wang H; Wang Y; Du Q; Lu P; Fan H; Lu J; Hu R
Exp Cell Res; 2016 Mar; 342(2):184-92. PubMed ID: 26968633
[TBL] [Abstract][Full Text] [Related]
27. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
Zinn R; Otterbein H; Lehnert H; Ungefroren H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells.
Wei J; Shi Y; Hou Y; Ren Y; Du C; Zhang L; Li Y; Duan H
Cell Signal; 2013 Dec; 25(12):2788-96. PubMed ID: 24041652
[TBL] [Abstract][Full Text] [Related]
29. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
30. Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells.
Zhu SM; Park YR; Seo SY; Kim IH; Lee ST; Kim SW
Intest Res; 2019 Oct; 17(4):527-536. PubMed ID: 31426622
[TBL] [Abstract][Full Text] [Related]
31. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway.
Luo W; Liu X; Sun W; Lu JJ; Wang Y; Chen X
Phytother Res; 2018 Oct; 32(10):2009-2020. PubMed ID: 29952428
[TBL] [Abstract][Full Text] [Related]
32. Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1.
Hahn JM; McFarland KL; Combs KA; Supp DM
Burns Trauma; 2016; 4(1):30. PubMed ID: 27574697
[TBL] [Abstract][Full Text] [Related]
33. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
34. TGF-β1 and TNF-α synergistically induce epithelial to mesenchymal transition of breast cancer cells by enhancing TAK1 activation.
Liao SJ; Luo J; Li D; Zhou YH; Yan B; Wei JJ; Tu JC; Li YR; Zhang GM; Feng ZH
J Cell Commun Signal; 2019 Sep; 13(3):369-380. PubMed ID: 30739244
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor superfamily member LIGHT induces epithelial-mesenchymal transition in A549 human alveolar epithelial cells.
Mikami Y; Yamauchi Y; Horie M; Kase M; Jo T; Takizawa H; Kohyama T; Nagase T
Biochem Biophys Res Commun; 2012 Nov; 428(4):451-7. PubMed ID: 23131560
[TBL] [Abstract][Full Text] [Related]
36. Enterolactone modulates the ERK/NF-κB/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-β-induced epithelial-mesenchymal transition.
Mali AV; Joshi AA; Hegde MV; Kadam SS
Cancer Biol Med; 2018 May; 15(2):137-156. PubMed ID: 29951338
[TBL] [Abstract][Full Text] [Related]
37. p38 maintains E-cadherin expression by modulating TAK1-NF-kappa B during epithelial-to-mesenchymal transition.
Strippoli R; Benedicto I; Foronda M; Perez-Lozano ML; Sánchez-Perales S; López-Cabrera M; Del Pozo MÁ
J Cell Sci; 2010 Dec; 123(Pt 24):4321-31. PubMed ID: 21098640
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
